Search
for
Sort by
Research 31–60 of 1000+
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
- Microneedles as a perspective for transdermal therapeutic systems
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Recent approaches of antibody therapeutics in androgenetic alopecia
- 260 Anti-OX40 monoclonal antibody IMG-007 exhibited clinical activity of hair regrowth, suppressed scalp inflammatory biomarkers in patients with severe alopecia areata in a Ph1b/2a study
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- Hypertrichosis of the pinnae in a patient using panitumumab
- Immunomodulators in the treatment of cutaneous lymphoma
- Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- Hair Growth in a Patient with Alopecia Areata on Tocilizumab
- Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab
- Targeting integrin pathways: mechanisms and advances in therapy
- Alopecia areata after belimumab use in a patient with systemic lupus erythematosus: a paradoxical case of autoimmunity
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Percutaneous drug delivery to the hair follicle
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- Alopecia areata after mogamulizumab treatment
- BI35 A case of dupilumab-induced scalp psoriasis and review of the literature
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
- Editorial: Targeted immunological therapies in dermatology
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- Efficacy of Dupilumab in Treating Atopic Dermatitis With Recurrent Eczema Herpeticum in a Patient With DOCK8-Deficiency Hyper-IgE Syndrome: A Case Report
- Cutaneous lesions and clinical outcomes in five cats after frunevetmab injections
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Dupilumab Induced Hair Regrowth in Alopecia Totalis
- Folliculitis decalvans managed with adalimumab: A case report
- Editorial: Prevention and treatment of skin diseases